Psychotic Disorders - Oman

  • Oman
  • Revenue in the Psychotic Disorders market is projected to reach US$8.85m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.02%, resulting in a market volume of US$9.31m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$2,257.00m in 2024).
  • In relation to total population figures, per person revenues of US$189.50 are generated in 2024.

Key regions: Japan, Australia, Europe, India, France

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Psychotic Disorders market in Oman is experiencing significant growth and development due to various factors.

Customer preferences:
Customers in Oman are increasingly seeking effective treatment options for psychotic disorders. They are looking for medications and therapies that can alleviate their symptoms and improve their quality of life. As a result, there is a growing demand for antipsychotic medications, psychotherapy services, and other supportive treatments in the market.

Trends in the market:
One of the key trends in the Psychotic Disorders market in Oman is the increasing adoption of newer antipsychotic medications. These medications have shown better efficacy and fewer side effects compared to older drugs, making them more attractive to both patients and healthcare providers. The market is witnessing a shift towards these newer medications, with a corresponding decline in the use of older drugs.Another trend in the market is the integration of technology in the treatment of psychotic disorders. Digital platforms and mobile applications are being developed to provide remote monitoring, self-help tools, and online therapy sessions. These technological advancements are making mental health services more accessible and convenient for patients, thereby driving the growth of the market.

Local special circumstances:
Oman has been actively working towards improving mental healthcare services in the country. The government has implemented various initiatives to raise awareness about mental health and reduce the stigma associated with psychotic disorders. This has resulted in increased acceptance and willingness among individuals to seek help for their conditions, leading to a higher demand for treatment options in the market.

Underlying macroeconomic factors:
The overall economic growth in Oman has contributed to the development of the Psychotic Disorders market. As the country's economy expands, individuals have more disposable income to spend on healthcare services. This has led to an increase in the affordability of treatments for psychotic disorders, driving the market growth.Additionally, the government's focus on healthcare infrastructure development has improved access to mental health services across the country. The establishment of specialized clinics and hospitals dedicated to mental health has increased the availability of treatment options for individuals with psychotic disorders. This has further fueled the growth of the market.In conclusion, the Psychotic Disorders market in Oman is witnessing significant growth and development due to increasing customer preferences for effective treatments, adoption of newer medications, integration of technology in mental healthcare, government initiatives to raise awareness, and the overall economic growth of the country. These factors are driving the demand for antipsychotic medications, psychotherapy services, and other supportive treatments in the market.

Methodology

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Patients
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)